William Blair & Company
DPLO

William Blair & Company’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

William Blair & Company’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200
Closed -$4K – 1652
2018
Q1 		$4K Sell
200
-500
-71% -$11.7K ﹤0.01% 1489
2017
Q4 		$14K Buy
+700
New +$13.8K ﹤0.01% 1356

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair & Company's DPLO Position: Q1 2019 in Review

William Blair & Company sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 50,485 shares — an estimated $1.02M sold.

William Blair & Company first reported a position in DPLO in Q1 2015 and held it in 14 quarters. The position peaked at $10.3M in Q3 2015. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • William Blair & Company reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • William Blair & Company sold 50,485 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $1.02M.
  • William Blair & Company first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 14 quarters.
  • William Blair & Company's DIPLOMAT PHARMACY, INC. position peaked at $10.3M in Q3 2015.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on William Blair & Company's 13F filing for Q1 2019, filed 14 May 2019.